News
An IV formulation created by faculty at the College of Pharmacy for topiramate, an antiseizure medication used to treat epilepsy, was submitted via a New Drug Application to the Food and Drug Administration (FDA) in October 2025 and is pending review this year.
Ahead of this year’s University of Minnesota Rare Disease Day event on March 5, Dr. James Cloyd answers questions about rare diseases and the work behind understanding them.
Competition raises collective knowledge of translational science education and training
The University of Minnesota and M Health Fairview’s Rare Disease Center of Excellence recently received $500,000 from the Wasie Foundation to support rare disease research and patients.
